Samantha McLemore - Patient Capital Management
Holding/activity history for DXC Technology Co. (DXC)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price |
| 2023 Q4 | 0 | 0 | Sell 100.00% | 1.47 | |
| 2023 Q3 | 1,198,173 | 1.47 | Add 1064.97% | 1.34 | $20.83 |
| 2023 Q2 | 102,850 | 0.15 | Add 71.42% | 0.06 | $26.72 |
| 2023 Q1 | 60,000 | 0.69 | Reduce 62.64% | 1.16 | $25.57 |
| 2022 Q4 | 160,600 | 2.10 | Reduce 15.47% | 0.38 | $26.50 |
| 2022 Q3 | 190,000 | 2.36 | Reduce 30.04% | 1.01 | $24.48 |
| 2022 Q2 | 271,600 | 4.04 | Reduce 9.95% | 0.45 | $30.31 |
| 2022 Q1 | 301,600 | 3.88 | Reduce 6.83% | 0.28 | $32.63 |
| 2021 Q4 | 323,700 | 4.22 | $32.19 |